Neuron
Volume 67, Issue 5, 9 September 2010, Pages 769-780
ArticleModulation of γ-Secretase Reduces β-Amyloid Deposition in a Transgenic Mouse Model of Alzheimer's Disease
Under an Elsevier user license
open archive
Highlights
► Over 1200 novel and potent gamma-secretase modulators were synthesized and tested ► Potent 2-aminothiazole GSMs decreased Aβ42 and Aβ40 and increased Aβ38 and Aβ37 ► A potent immobilized GSM derivative quantitatively recovered Pen-2 ► Potent GSM compounds did not inhibit epsilon cleavages of either APP, Notch, or E-cad
Cited by (0)
- 6
These authors contributed equally to this work
- 7
Present address: Neurogenetic Pharmaceuticals, Inc., San Diego, CA 92121, USA
- 8
Present address: Helicon Therapeutics, Inc., San Diego, CA 92121, USA
- 9
Present address: CalciMedica, Inc., La Jolla, CA 92037, USA
- 10
Present address: Department of Neurosciences, University of California, San Diego, La Jolla, CA 92037, USA
Copyright © 2010 Elsevier Inc. All rights reserved.